Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1307125.RA0CBNhMTvsc9R7el6sRVe7rJbV4z7C1iLnCfFaDkaMsk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1307125.RA0CBNhMTvsc9R7el6sRVe7rJbV4z7C1iLnCfFaDkaMsk130_assertion type Assertion NP1307125.RA0CBNhMTvsc9R7el6sRVe7rJbV4z7C1iLnCfFaDkaMsk130_head.
- NP1307125.RA0CBNhMTvsc9R7el6sRVe7rJbV4z7C1iLnCfFaDkaMsk130_assertion description "[Although reduced acid beta-glucosidase activity appears to be the primary enzyme defect in type I Gaucher disease, patients with this disorder also have marked elevation of serum acid phosphatase and beta-hexosaminidase activities but with a normal level of lactic dehydrogenase activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1307125.RA0CBNhMTvsc9R7el6sRVe7rJbV4z7C1iLnCfFaDkaMsk130_provenance.
- NP1307125.RA0CBNhMTvsc9R7el6sRVe7rJbV4z7C1iLnCfFaDkaMsk130_assertion evidence source_evidence_literature NP1307125.RA0CBNhMTvsc9R7el6sRVe7rJbV4z7C1iLnCfFaDkaMsk130_provenance.
- NP1307125.RA0CBNhMTvsc9R7el6sRVe7rJbV4z7C1iLnCfFaDkaMsk130_assertion SIO_000772 6859103 NP1307125.RA0CBNhMTvsc9R7el6sRVe7rJbV4z7C1iLnCfFaDkaMsk130_provenance.
- NP1307125.RA0CBNhMTvsc9R7el6sRVe7rJbV4z7C1iLnCfFaDkaMsk130_assertion wasDerivedFrom befree-2016 NP1307125.RA0CBNhMTvsc9R7el6sRVe7rJbV4z7C1iLnCfFaDkaMsk130_provenance.
- NP1307125.RA0CBNhMTvsc9R7el6sRVe7rJbV4z7C1iLnCfFaDkaMsk130_assertion wasGeneratedBy ECO_0000203 NP1307125.RA0CBNhMTvsc9R7el6sRVe7rJbV4z7C1iLnCfFaDkaMsk130_provenance.